Foundayo Online: How the Prescription Process Works

• A stage by stage walkthrough of what actually happens, not a vague overview
• Explains what each consultation question is for, so answers are easier to give accurately
• Covers why a request may be declined, and what that means
• Online consultation with UK registered prescribers, with clinical assessment before any supply.

Foundayo is a prescription only medicine, so there is no version of this process that skips a clinical assessment. Requesting it online does not mean choosing it from a page and paying. It means completing a consultation, having that information reviewed by a registered prescriber, and receiving a decision that may be yes, may be no, and may be a different treatment.

That is the part worth understanding before you start, because it changes what the process is for. An online consultation is not a formality standing between you and a product. It is the assessment that determines whether the product is appropriate for you at all, and a service where that assessment could never result in a no is not operating properly.

Foundayo contains orforglipron and was approved by the MHRA on 10 August 2026 for weight loss and weight maintenance in adults alongside a reduced calorie diet and increased physical activity, and separately for blood sugar control in type 2 diabetes that is not adequately controlled. This article walks through each stage of the online process, what the questions are for, what to prepare, and what happens after treatment starts.

Key things to know

• Foundayo is prescription only in the UK, and no legitimate route supplies it without an assessment
• The process runs in five stages: consultation, prescriber review, decision, dispensing and delivery, then follow up
• The consultation covers medical history, current medicines, weight history and specific conditions
• A registered prescriber reviews your information independently before anything is supplied
• Requests are declined where treatment is not appropriate, which is the assessment working
• Follow up is part of treatment rather than an optional extra, because response is monitored over time
• Difficulty with the process is common, and accurate answers matter more than fast ones

Do you need a prescription for Foundayo?

Yes. Foundayo is classified as a prescription only medicine in the UK, which means it can be supplied only against a prescription written by an appropriate prescriber, and dispensed by a registered pharmacy.

This is not a paperwork requirement. The classification reflects the fact that the medicine is not suitable for everyone, that eligibility depends on factors only an assessment can establish, and that side effects need monitoring. That is why professional medical advice is required before using a weight loss medication. A prescriber is deciding whether the balance of benefit and risk works for you specifically.

The five stages, start to finish

Here is the whole process in one place, with the rest of the article explaining each stage.

Two things about that sequence catch people out. The decision is not automatic after payment, and a request for more information is a normal part of stage three rather than a problem. Both reflect an assessment being done properly rather than processed.

Stage one: the online consultation

The consultation is a structured medical questionnaire covering your height and weight, body mass index, medical history, current medicines, previous weight management attempts and specific conditions that affect suitability for weight loss treatment. It usually takes a short time to complete, and the accuracy of the answers matters far more than the speed.

An online consultation with a UK-registered prescriber can cover many of the same clinical areas as an in-person assessment, including your medical history, current medicines, weight and relevant health conditions. The format is different, however, and the prescriber may decide that an in-person assessment or additional information is needed before treatment can be prescribed.

Why each question is asked

Understanding the purpose behind the questions makes them easier to answer properly, and it removes the temptation to give the answer you think unlocks treatment.

The eating pattern question deserves a note, because people sometimes skip it or answer defensively. It is asked because appetite acting medicines interact with eating patterns in ways that can be harmful in some circumstances. An honest answer protects you, and it does not automatically mean a no.

What to prepare before you start

• Your current height and weight, measured rather than estimated
• A list of every medicine you take, including anything bought without a prescription
• Any supplements, since these count and are often forgotten
• Names of conditions you have been diagnosed with, and roughly when
• Details of any previous weight management treatment and what happened
• Relevant family history, particularly thyroid conditions
• Any allergies or previous reactions to medicines

Having these to hand turns a stop start process into a single sitting, and it reduces the chance of stage three coming back as a request for more information.

Why accuracy matters more than the answer you think they want

There is a temptation, when a questionnaire stands between you and something you want, to shade an answer. It is understandable, and it is the one thing that causes problems later more often than anything else.

The consultation is how the prescriber identifies interactions, conditions that change suitability and situations where a different treatment is the right fit. An inaccurate answer does not remove the risk it was hiding, it removes the prescriber's ability to see it. If a condition would have made this treatment unsuitable, it still does once treatment starts.

There is also a practical point. Inconsistencies between answers are noticeable, and they usually result in a request for clarification rather than a quiet approval, which slows things down rather than speeding them up.

Stage two: prescriber review

A registered prescriber reviews your consultation answers and decides whether treatment is appropriate.

For weight management, the UK authorisation covers adults with an initial BMI of 30 kg/m² or above, or a BMI of at least 27 kg/m² but below 30 kg/m² with at least one weight-related comorbidity. Foundayo is used alongside a reduced-calorie diet and increased physical activity.

Meeting the BMI criteria does not by itself guarantee a prescription. The prescriber also considers your medical history, current medicines, other relevant health factors and whether the treatment is appropriate for you.

Stage three: the decision

Three outcomes are possible, and only one of them is a straightforward yes.

Why a request may be declined

Declines are not arbitrary, and understanding the common reasons removes the sense that something went wrong.

1. Not meeting the licensed criteria, including BMI thresholds
2. A medical condition that makes this family of treatment unsuitable
3. An interaction with a medicine you already take
4. Pregnancy, planning pregnancy or breastfeeding
5. A history that makes appetite acting treatment inappropriate
6. Information that is incomplete or inconsistent
7. Something that needs assessing in person first

A decline for reasons six or seven is not permanent. It usually means the assessment cannot be completed safely with the information available, and providing what is missing or being seen in person resolves it.

If you are declined, the useful next step is to read the reason given and act on it, rather than trying the same request elsewhere. A different service applying the same standards should reach the same conclusion, and one that does not is a service to be wary of.

Stage four: dispensing and delivery

Once approved, a pharmacy registered with the General Pharmaceutical Council dispenses the medicine against the prescription and arranges dispatch. Registration matters here because it is what makes the supply chain accountable.

What arrives should include the medicine itself, the patient information leaflet and clear labelling. Read the leaflet before you start, even if you have read a summary somewhere. It contains the specific information for your product, including what to do about a missed dose, and a general article is not a substitute for it.

Never double up after a missed dose to catch up, and follow the instructions supplied with your treatment rather than instructions found elsewhere.

Foundayo delivery in the UK

Foundayo is a once-daily tablet. Unlike some medicines that need to be taken at a particular time or around meals, the UK product information states that Foundayo can be taken at any time of day, with or without food or water restrictions. The tablet should be swallowed whole and should not be broken, crushed or chewed.

When your medicine arrives, check the name, strength and labelling against what was prescribed. If something does not match your prescription or the packaging appears unusual, contact the dispensing pharmacy before taking the medicine.

Stage five: follow up and review

Follow up exists because response and side effects are monitored over time, and treatment is adjusted accordingly. It is part of treatment rather than an add on, and a service without it is missing something structural rather than optional.

Review typically covers how your weight has responded, what side effects you have experienced, whether anything has changed in your health or medicines, and whether continuing is appropriate. For Foundayo specifically, gastrointestinal effects such as nausea, constipation, diarrhoea, vomiting, dyspepsia and abdominal pain are among the most frequently reported adverse reactions

Spotting a supply route that is not legitimate

Newly approved medicines attract offers that bypass the assessment, particularly while supply is limited. These are the signals that something is wrong, and any one of them is enough.

• No medical questionnaire, or a token one with no clinical content
• No named, registered prescriber involved at any point
• No pharmacy registration details available to check
• Claims of stock before general availability is established
• Pressure to order quickly, or language implying limited windows
• Supply offered through social media or messaging apps
• Packaging or labelling not in English, or not matching UK requirements
• No route provided for reporting side effects or asking questions

Registration can be checked on the regulator's own register rather than taken from a logo on a page. Medicines obtained outside the regulated supply chain carry risks around authenticity, storage and content that no convenience justifies, and there is no recourse when something goes wrong.

Availability of Foundayo as a weight loss treatment and realistic expectations

For context, clinical trials have reported different average weight-loss results for different medicines, doses and study populations. In the 72-week ATTAIN-1 trial, the highest studied dose of orforglipron was associated with a 12.4% mean reduction in body weight.

Other medicines have produced different results in their own trials. Oral semaglutide 25 mg produced an average weight reduction of 16.6% at 64 weeks among participants who remained on treatment in OASIS-4, while the treatment-policy analysis showed a 13.6% reduction. Higher-dose injectable semaglutide 7.2 mg produced about 21% mean weight loss at 72 weeks in the STEP UP trial, while tirzepatide 15 mg produced 22.5% in the 72-week SURMOUNT-1 trial.

These figures come from different trials, doses and populations, so they should not be treated as a direct head-to-head comparison or as a prediction of how much weight any individual will lose. Your response will depend on factors including the treatment, dose, duration and your own health and circumstances.

Medical Disclaimer

This article is for general information only and does not replace personal medical advice. Orforglipron is a non-peptide small molecule medicine, which helps explain why Foundayo is provided as a daily tablet. It should not be used to decide on a treatment, to start or stop any medicine, or to delay seeking help. Foundayo is a prescription only medicine, and eligibility is determined by an individual clinical assessment rather than by meeting any single criterion.

Always read the patient information leaflet supplied with your treatment, and speak to a pharmacist, GP or prescriber about your own circumstances and every medicine you take. General information should not replace professional medical advice before you get Foundayo online. Regulatory status and availability change, so confirm the current position before acting on anything here. Report suspected side effects through the Yellow Card scheme.